HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

Abstract
Natural killer (NK) cells were first identified for their capacity to reject bone marrow allografts in lethally irradiated mice without prior sensitization. Subsequently, human NK cells were detected and defined by their non-major histocompatibility complex (MHC)-restricted cytotoxicity toward transformed or virally infected target cells. Karre et al. later proposed 'the missing self hypothesis' to explain the mechanism by which self-tolerant cells could kill targets that had lost self MHC class I. Subsequently, the receptors that recognize MHC class I to mediate tolerance in the host were identified on NK cells. These class I-recognizing receptors contribute to the acquisition of function by a dynamic process known as NK cell education or licensing. In the past, NK cells were assumed to be short lived, but more recently NK cells have been shown to mediate immunologic memory to secondary exposures to cytomegalovirus infection. Because of their ability to lyse tumors with aberrant MHC class I expression and to produce cytokines and chemokines upon activation, NK cells may be primed by many stimuli, including viruses and inflammation, to contribute to a graft-versus-tumor effect. In addition, interactions with other immune cells support the therapeutic potential of NK cells to eradicate tumor and to enhance outcomes after hematopoietic cell transplantation.
AuthorsBree Foley, Martin Felices, Frank Cichocki, Sarah Cooley, Michael R Verneris, Jeffrey S Miller
JournalImmunological reviews (Immunol Rev) Vol. 258 Issue 1 Pg. 45-63 (Mar 2014) ISSN: 1600-065X [Electronic] England
PMID24517425 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Copyright© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • Receptors, Natural Killer Cell
Topics
  • Animals
  • Graft Rejection (immunology, prevention & control)
  • Graft Survival
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Immune Tolerance
  • Immunity, Innate
  • Immunologic Memory
  • Killer Cells, Natural (immunology, metabolism)
  • Lymphocyte Activation
  • Receptors, Natural Killer Cell (immunology, metabolism)
  • Signal Transduction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: